Jan 30 (Reuters) - India's Dr Lal Path Labs (DLPA.NS), opens new tab reported a 19% jump in its third-quarter profit on Thursday, led by continued demand for its bundle test offerings, sending its ...
April 25 (Reuters) - Dr Lal Path Labs (DLPA.NS), opens new tab, India's largest diagnostics firm by revenue, reported fourth-quarter profit above expectations on Friday as strong demand for its ...
Here's an analysis of the annual report of DR. LAL PATHLABS for 2024-25. It includes a full income statement, balance sheet and cash flow analysis of DR. LAL PATHLABS. Also includes updates on the ...
Dr Lal PathLabs on Friday announced its Q3 results, reporting a year-on-year increase in revenue while net profit declined. Dr Lal PathLabs on Friday announced its Q3 results. Image Credit: Freepik Dr ...
Jan 30 (Reuters) - Dr. Lal Path Labs reported a lower third-quarter profit on Friday after taking a one-time charge linked to India’s new labour code, despite strong demand for its bundled test ...
Add Yahoo as a preferred source to see more of our stories on Google. (Refiles to remove extraneous link in paragraph 1) April 30 (Reuters) - Dr Lal Path Labs reported a 15.5% drop in fourth-quarter ...
Dr. Lal Path Labs shares have shown a steady upward trend across most timeframes, outperforming the broader Nifty 500 and reflecting strong investor interest around the company’s growth outlook and ...
Stocks to buy for short term: Market benchmarks the Sensex and the Nifty 50 clocked a healthy gain of 1.6 per cent for the week ended November 14, driven by hopes of an India-US trade deal amid better ...
Dr. Lal PathLabs is lining up a decisive acquisition drive to consolidate India’s hyper‑local diagnostics market, with Group CFO and International CEO Ved Goel signalling that the company is now “a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results